Efficacy of etanercept in lymphedema associated with psoriatic arthritis.
Identifieur interne : 002F77 ( PubMed/Curation ); précédent : 002F76; suivant : 002F78Efficacy of etanercept in lymphedema associated with psoriatic arthritis.
Auteurs : Fernando Kemta Lekpa ; Andra Economu-Dubosc ; Claire Fevre ; Pascal Claudepierre ; Xavier ChevalierSource :
- The Journal of rheumatology [ 0315-162X ] ; 2009.
Descripteurs français
- KwdFr :
- Adulte, Antirhumatismaux (usage thérapeutique), Arthrite psoriasique (), Arthrite psoriasique (traitement médicamenteux), Humains, Immunoglobuline G (usage thérapeutique), Lymphoedème (traitement médicamenteux), Lymphoedème (étiologie), Mâle, Récepteurs aux facteurs de nécrose tumorale (usage thérapeutique), Étanercept.
- MESH :
- traitement médicamenteux : Arthrite psoriasique, Lymphoedème.
- usage thérapeutique : Antirhumatismaux, Immunoglobuline G, Récepteurs aux facteurs de nécrose tumorale.
- étiologie : Lymphoedème.
- Adulte, Arthrite psoriasique, Humains, Mâle, Étanercept.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Antirheumatic Agents, Immunoglobulin G, Receptors, Tumor Necrosis Factor.
- complications : Arthritis, Psoriatic.
- drug therapy : Arthritis, Psoriatic, Lymphedema.
- etiology : Lymphedema.
- Adult, Etanercept, Humans, Male.
DOI: 10.3899/jrheum.080453
PubMed: 19208540
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002F77
Links to Exploration step
pubmed:19208540Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficacy of etanercept in lymphedema associated with psoriatic arthritis.</title>
<author><name sortKey="Lekpa, Fernando Kemta" sort="Lekpa, Fernando Kemta" uniqKey="Lekpa F" first="Fernando Kemta" last="Lekpa">Fernando Kemta Lekpa</name>
</author>
<author><name sortKey="Economu Dubosc, Andra" sort="Economu Dubosc, Andra" uniqKey="Economu Dubosc A" first="Andra" last="Economu-Dubosc">Andra Economu-Dubosc</name>
</author>
<author><name sortKey="Fevre, Claire" sort="Fevre, Claire" uniqKey="Fevre C" first="Claire" last="Fevre">Claire Fevre</name>
</author>
<author><name sortKey="Claudepierre, Pascal" sort="Claudepierre, Pascal" uniqKey="Claudepierre P" first="Pascal" last="Claudepierre">Pascal Claudepierre</name>
</author>
<author><name sortKey="Chevalier, Xavier" sort="Chevalier, Xavier" uniqKey="Chevalier X" first="Xavier" last="Chevalier">Xavier Chevalier</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19208540</idno>
<idno type="pmid">19208540</idno>
<idno type="doi">10.3899/jrheum.080453</idno>
<idno type="wicri:Area/PubMed/Corpus">002F77</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002F77</idno>
<idno type="wicri:Area/PubMed/Curation">002F77</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002F77</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Efficacy of etanercept in lymphedema associated with psoriatic arthritis.</title>
<author><name sortKey="Lekpa, Fernando Kemta" sort="Lekpa, Fernando Kemta" uniqKey="Lekpa F" first="Fernando Kemta" last="Lekpa">Fernando Kemta Lekpa</name>
</author>
<author><name sortKey="Economu Dubosc, Andra" sort="Economu Dubosc, Andra" uniqKey="Economu Dubosc A" first="Andra" last="Economu-Dubosc">Andra Economu-Dubosc</name>
</author>
<author><name sortKey="Fevre, Claire" sort="Fevre, Claire" uniqKey="Fevre C" first="Claire" last="Fevre">Claire Fevre</name>
</author>
<author><name sortKey="Claudepierre, Pascal" sort="Claudepierre, Pascal" uniqKey="Claudepierre P" first="Pascal" last="Claudepierre">Pascal Claudepierre</name>
</author>
<author><name sortKey="Chevalier, Xavier" sort="Chevalier, Xavier" uniqKey="Chevalier X" first="Xavier" last="Chevalier">Xavier Chevalier</name>
</author>
</analytic>
<series><title level="j">The Journal of rheumatology</title>
<idno type="ISSN">0315-162X</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antirheumatic Agents (therapeutic use)</term>
<term>Arthritis, Psoriatic (complications)</term>
<term>Arthritis, Psoriatic (drug therapy)</term>
<term>Etanercept</term>
<term>Humans</term>
<term>Immunoglobulin G (therapeutic use)</term>
<term>Lymphedema (drug therapy)</term>
<term>Lymphedema (etiology)</term>
<term>Male</term>
<term>Receptors, Tumor Necrosis Factor (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Antirhumatismaux (usage thérapeutique)</term>
<term>Arthrite psoriasique ()</term>
<term>Arthrite psoriasique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Immunoglobuline G (usage thérapeutique)</term>
<term>Lymphoedème (traitement médicamenteux)</term>
<term>Lymphoedème (étiologie)</term>
<term>Mâle</term>
<term>Récepteurs aux facteurs de nécrose tumorale (usage thérapeutique)</term>
<term>Étanercept</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antirheumatic Agents</term>
<term>Immunoglobulin G</term>
<term>Receptors, Tumor Necrosis Factor</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Arthritis, Psoriatic</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Arthritis, Psoriatic</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Arthrite psoriasique</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirhumatismaux</term>
<term>Immunoglobuline G</term>
<term>Récepteurs aux facteurs de nécrose tumorale</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Etanercept</term>
<term>Humans</term>
<term>Male</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Arthrite psoriasique</term>
<term>Humains</term>
<term>Mâle</term>
<term>Étanercept</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19208540</PMID>
<DateCreated><Year>2009</Year>
<Month>02</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted><Year>2009</Year>
<Month>03</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0315-162X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>36</Volume>
<Issue>1</Issue>
<PubDate><Year>2009</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of rheumatology</Title>
<ISOAbbreviation>J. Rheumatol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Efficacy of etanercept in lymphedema associated with psoriatic arthritis.</ArticleTitle>
<Pagination><MedlinePgn>207-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3899/jrheum.080453</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lekpa</LastName>
<ForeName>Fernando Kemta</ForeName>
<Initials>FK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Economu-Dubosc</LastName>
<ForeName>Andra</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Fevre</LastName>
<ForeName>Claire</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Claudepierre</LastName>
<ForeName>Pascal</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chevalier</LastName>
<ForeName>Xavier</ForeName>
<Initials>X</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Canada</Country>
<MedlineTA>J Rheumatol</MedlineTA>
<NlmUniqueID>7501984</NlmUniqueID>
<ISSNLinking>0315-162X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018124">Receptors, Tumor Necrosis Factor</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>OP401G7OJC</RegistryNumber>
<NameOfSubstance UI="D000068800">Etanercept</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015535" MajorTopicYN="N">Arthritis, Psoriatic</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000068800" MajorTopicYN="N">Etanercept</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018124" MajorTopicYN="N">Receptors, Tumor Necrosis Factor</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>2</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>2</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19208540</ArticleId>
<ArticleId IdType="pii">36/1/207</ArticleId>
<ArticleId IdType="doi">10.3899/jrheum.080453</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F77 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002F77 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:19208540 |texte= Efficacy of etanercept in lymphedema associated with psoriatic arthritis. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:19208540" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |